Advanced NanoTherapies, Inc. is a privately held medical device company committed to using nanotechnology for enhanced drug uptake and sustained retention in the cell for medical devices. We are primarily focused on cardiovascular and endovascular applications and dedicated to bringing a safer therapeutic option to peripheral artery disease (PAD) patients using Sirolimus-coated angioplasty balloons.
Marwan Berrada-Sounni, CEO
2018
Advanced NanoTherapies incorporated as a Delaware C-Corp2019
Licensed technology from Cleveland Clinic (September)2020
Operation started in January Closed on $5.3M Financing2018
Advanced NanoTherapies incorporated as a Delaware C-Corp2019
Licensed technology from Cleveland Clinic (September)2020
Operation started in January Closed on $5.3M FinancingCEO: Marwan Berrada-Sounni, MSc, MBA
A successful entrepreneur with extensive experience in cardiovascular and endovascular devices.
CMO: Mehdi Shishehbor, DO, MPH, PhD
Chief Medical Officer and President, Harrington Heart and Vascular Institute University Hospitals, Cleveland
Vinod Labhasetwar, PhD
Professor and Endowed Chair of Nanomedicine, Department of Biomedical Engineering at Cleveland Clinic Lerner Research